Discovery and development of a novel, class I Core protein Assembly Modulator (CpAM) for the treatment of chronic HBV infection

被引：0

作者：

Zhu, Wei ^{[1
]}

机构：

[1] Roche RD Ctr China Ltd, Shanghai, Peoples R China

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 258卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

244-MEDI

引用

页数：1

共 50 条

[1] Novel Therapeutics in Discovery and Development for Treatment of Chronic HBV Infection
Hu, Yimin
Zhu, Wei
Tang, Guozhi
Mayweg, Alexander V.
Yang, Guang
Wu, Jim Z.
Shen, Hong C.
[J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 265 - 281
[2] Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV Infection
Zhang, Weixing
Guo, Lei
Liu, Haixia
Wu, Guolong
Shi, Houguang
Zhou, Mingwei
Zhang, Zhisen
Kou, Buyu
Hu, Taishan
Zhou, Zheng
Xu, Zhiheng
Zhou, Xue
Zhou, Yuan
Tian, Xiaojun
Yang, Guang
Young, John A. T.
Qiu, Hongxia
Ottaviani, Giorgio
Xie, Jianxun
Mayweg, Alexander, V
Shen, Hong C.
Zhu, Wei
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (06) : 4253 - 4270
[3] Preclinical characterization of a novel potent core protein assembly modulator for the treatment of chronic hepatitis B viral infection
Dunkoksung, Wilasinee
Udomnilobol, Udomsak
Ruengsatra, Tanachote
Chauypen, Natthaya
Prueksaritanont, Thomayant
[J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 200
[4] Phase 1a Safety and Pharmacokinetics (PK) of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM) For The Treatment of Chronic HBV Infection
Gane, Edward J.
Schwabe, Christian
Liaw, Sandy
Ruby, Eric
Li, Leping
Chan, Kelvin
Patel, Kashyap
Smith, Patrick
Colonno, Richard
Lopatin, Uri A.
[J]. HEPATOLOGY, 2017, 66 : 495A - 495A
[5] Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein
Zheng, Yuan
Yang, Le
Yu, Lin
Zhu, Yuanfei
Wu, Yang
Zhang, Zhijun
Xia, Tian
Deng, Qiang
[J]. VIRUSES-BASEL, 2023, 15 (05):
[6] Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection
Burdette, Dara
Hyrina, Anastasia
Song, Zhijuan
Beran, Rudolf K.
Cheung, Tara
Gilmore, Sarah
Kobayashi, Tetsuya
Li, Li
Liu, Yang
Niedziela-Majka, Anita
Medley, Jonathan
Mehra, Upasana
Morganelli, Philip
Novikov, Nikolai
Niu, Congrong
Tam, Danny
Tang, Jennifer
Wang, Jianhong
Yue, Qin
Fletcher, Simon P.
Holdorf, Meghan M.
Delaney, William E.
Feierbach, Becket
Lazerwith, Scott
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (01)
[7] Discovery of SHR5133, a Highly Potent and Novel HBV Capsid Assembly Modulator
Li, Xin
Zhang, Zhigao
Chen, Yang
Wang, Bin
Yang, Guimei
Xu, Xiangbin
Yechao, Baihui
Bai, Dongdong
Feng, Binqiang
Mao, Yuchang
Feng, Jun
Bai, Chang
He, Feng
Tao, Weikang
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (03): : 507 - 512
[8] Novel HBV capsid assembly modulator inhibits pregenomic RNA encapsidation by accelerating capsid assembly kinetics and disrupting core protein dephosphorylation
Bassit, Leda
Verma, Kiran
Ono, Suzane Kioko
Cox, Bryan
Amblard, Franck
Schinazi, Raymond F.
[J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E457 - E457
[9] Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection
Feng, Song
Gao, Lu
Han, Xingchun
Hu, Taishan
Hu, Yimin
Liu, Haixia
Thomas, Andrew W.
Yan, Zhipeng
Yang, Song
Young, John A. T.
Yun, Hongying
Zhu, Wei
Shen, Hong C.
[J]. ACS INFECTIOUS DISEASES, 2018, 4 (03): : 257 - 277
[10] Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation
Berke, Jan Martin
Tan, Ying
Sauviller, Sarah
Wu, Dai-tze
Zhang, Ke
Conceicao-Neto, Nadia
Blazquez Moreno, Alfonso
Kong, Desheng
Kukolj, George
Li, Chris
Zhu, Ren
Najera, Isabel
Pauwels, Frederik
[J]. JOURNAL OF VIROLOGY, 2024, 98 (03)

← 1 2 3 4 5 →